India is probably the only or one of the few pharma markets where we have a third category (branded generics) in addition to branded and generic medicines. The CCI’s recent policy note on ‘Making Markets Work for Affordable Healthcare’, comes down heavily
India is probably the only or one of the few pharma markets where we have a third category (branded generics) in addition to branded and generic medicines. The CCI’s recent policy note on ‘Making Markets Work for Affordable Healthcare’, comes down heavily